Results 1 to 10 of about 43,943 (196)
Shift work and use of psychotropic medicine: a follow-up study with register linkage [PDF]
Scandinavian Journal of Work, Environment & Health, 2020 OBJECTIVE: This study aimed to investigate a prospective association between shift work and use of psychotropic medicine. METHODS: Survey data from random samples of the general working population of Denmark (N=19 259) were linked to data from national ...
Karen Albertsen +3 more
doaj +2 more sources
Rational prescribing of psychotropic medicines [PDF]
International Psychiatry, 2004 The progressive development of effective psychotropic medicines over the past 50 years has undoubtedly revolutionised the care of people with a mental illness, so that they now have a very important role in modern health care. Increasingly, however, concern is being expressed in a number of countries about the excessive use of these medications ...
Hamid Ghodse
openalex +4 more sources
Psychotropic Medicines and Aggressive Behavior [PDF]
Child and Adolescent Psychopharmacology News, 2002 In this, and two other articles that will appear in future issues of CAPN, we shall examine the effects of various psychotropic agents for managing aggression and antisocial behavior in children and adolescents. In most cases, the target behaviors will be in the context of a Disruptive Behavior Disorder (DBD), which will be discussed below.
Michael G. Aman, Ronald L. Lindsay
openalex +3 more sources
Psychotropic complementary medicines [PDF]
British Journal of Psychiatry, 2006 The recent review by Werneke et al ([2006][1]) contains substantive errors and omissions regarding the iboga alkaloid ibogaine and its synthetic congener 18-methoxycoronaridine (18-MC). The review cites a single paper published in 1994 consisting of seven case reports and overlooks two ...
Kenneth Alper, S.D. Glick
openalex +3 more sources
Psychological medicine. Psychotropic drugs in general practice. [PDF]
BMJ, 1975 Earlier articles in this series have examined the indications for prescribing in a wide range of diseases and for defined prob lems in the hospital setting and in general practice. They have highlighted the side effects of most relevance to the patient and to try to repeat or even summarize this information would be regarded as unnecessary.
J. G. R. Howie
openalex +5 more sources
Elderly people with mental disorders: experiencing the use of psychotropic medicines [PDF]
Revista Brasileira de Enfermagem, 2018 ABSTRACT Objective: To interpret the experience of the elderly with mental disorder in the use of psychotropic medicines. Method: Qualitative study in the interpretative modality, supported by the Grounded Theory. It was carried out from interviews with 16 elderly people with mental disorder and six relatives, totaling 22 participants.
María José Sanches Marín +2 more
+10 more sources
Safety of psychotropic medicines: looking beyond randomised evidence [PDF]
Epidemiology and Psychiatric Sciences, 2018 [no abstract available]
Corrado Barbui, Scott B. Patten
openalex +4 more sources
Utilization of psychotropic medicines in Romania during 1998–2018 [PDF]
Frontiers in Pharmacology, 2023 Background: Mental disorders can have a significant impact on patients’ life, including economic, social and individual consequences, and psychotropic medication is essential to treat these conditions. Psychotropic drug utilization studies contribute to a clearer picture of the management of these conditions.
Irina Iaru +8 more
openalex +4 more sources
Resisting psychotropic medicines: a synthesis of qualitative studies of medicine-taking [PDF]
Advances in Psychiatric Treatment, 2010 SummaryThis article reports the results of a synthesis of qualitative research articles about lay perspectives on prescribed psychotropic medicines. It updates and elaborates on a model of medicine-taking developed by Pound and colleagues. In this model, the concept of resistance refers to the various ways in which people take prescribed medicines ...
Nicky Britten +2 more
openalex +3 more sources
The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries. [PDF]
PLoS Medicine, 2012 BackgroundNeuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons ...
Ryan McBain +4 more
doaj +3 more sources